Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (221-230 of 251) with videos related to

Pageof 26
Sort By:
Leukemia|October 27, 1997
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemiaH M Kantarjian, S M O'Brien, M Keating, et al.
Blood|December 12, 2001
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blastsE H Estey, P F Thall, J E Cortes, et al.
Leukemia|March 1, 1996
Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemiaH M Kantarjian, M Beran, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factorH M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Experimental Hematology|March 1, 1992
KBM-3, an in vitro model of human acute myelomonocytic leukemiaB S Andersson, U S Bergerheim, V P Collins, et al.
Cancer Research|September 1, 1992
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemiaS M Kornblau, H J Xu, A del Giglio, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Blood|June 11, 1999
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemiaS O'Brien, H Kantarjian, C Koller, et al.
Bone Marrow Transplantation|March 14, 2003
Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemiaA-M Tsimberidou, J Medina, M Earl, et al.
Blood|January 1, 1988
Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemiaC Hirsch-Ginsberg, C Childs, K S Chang, et al.
Pageof 26

Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Leukemia|October 27, 1997
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemiaH M Kantarjian, S M O'Brien, M Keating, et al.
Blood|December 12, 2001
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blastsE H Estey, P F Thall, J E Cortes, et al.
Leukemia|March 1, 1996
Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemiaH M Kantarjian, M Beran, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factorH M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Experimental Hematology|March 1, 1992
KBM-3, an in vitro model of human acute myelomonocytic leukemiaB S Andersson, U S Bergerheim, V P Collins, et al.
Cancer Research|September 1, 1992
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemiaS M Kornblau, H J Xu, A del Giglio, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Blood|June 11, 1999
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemiaS O'Brien, H Kantarjian, C Koller, et al.
Bone Marrow Transplantation|March 14, 2003
Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemiaA-M Tsimberidou, J Medina, M Earl, et al.
Blood|January 1, 1988
Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemiaC Hirsch-Ginsberg, C Childs, K S Chang, et al.
Pageof 26